Clinical characteristics, patient selection and clinical outcomes of tafamidis treatment in transthyretin amyloidosis cardiomyopathy

被引：0
|
作者：
Takashio, S. [1 ]
Morioka, M. [1 ]
Fujiyama, A. [1 ]
Oike, F. [1 ]
Hanatani, S. [1 ]
Usuku, H. [1 ]
Yamamoto, E. [1 ]
Matsushita, K. [1 ]
Tsujita, K. [1 ]
机构：
[1] Kumamoto Univ Hosp, Kumamoto, Japan
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：964 / 964
页数：1
相关论文
共 50 条
  • [21] Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis
    Saith, Sunil E.
    Gamino, Danilo
    Teruya, Sergio
    Guadalupe, Samantha
    Helmke, Stephen
    Santos, Jeffeny De Los
    Goldsmith, Jeff
    Rosenblum, Hannah R.
    Griffin, Jan M.
    Maurer, Mathew S.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2021, 28 (04): : 267 - 268
  • [22] Diflunisal versus tafamidis on neuropathy and cardiomyopathy in hereditary transthyretin amyloidosis
    Chao, Chi-Chao
    Tzeng, Shiou-Ru
    Chiang, Ming-Chang
    Hsueh, Hsueh-Wen
    Hsieh, Wan-Jen
    Chao, Yuan-Chun
    Cheng, Mei-Fang
    Lin, Yen-Hung
    Su, Mao-Yuan
    Huang, Chun-Hsiang
    Wang, Yi-Shiang
    Hsieh, Ming-Fang
    Tseng, Ping-Huei
    Hsieh, Sung-Tsang
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (09): : 2426 - 2438
  • [23] Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy
    Takashio, Seiji
    Morioka, Mami
    Ishii, Masanobu
    Morikawa, Kei
    Hirakawa, Kyoko
    Hanatani, Shinsuke
    Oike, Fumi
    Usuku, Hiroki
    Kidoh, Masafumi
    Oda, Seitaro
    Yamamoto, Eiichiro
    Matsushita, Kenichi
    Ueda, Mitsuharu
    Tsujita, Kenichi
    ESC HEART FAILURE, 2023, 10 (04): : 2319 - 2329
  • [24] Efficacy and Safety of Tafamidis Doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT)
    Hanna, Mazen
    Damy, Thibaud
    Garcia-Pavia, Pablo
    Judge, Daniel P.
    Merlini, Giampaolo
    Maurer, Mathew S.
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Witteles, Ronald
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S77 - S78
  • [25] CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENT WITH HEREDITARY TRANSTHYRETIN CARDIAC AMYLOIDOSIS UNDERGOING ORTHOTOPIC HEART TRANSPLANT
    Brown, Matthew T.
    Yalamanchili, Sreeram
    Blank, Evan
    Lyle, Melissa
    Bhatt, Kunal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 825 - 825
  • [26] Tafamidis A Novel Treatment for Transthyretin Amyloid Cardiomyopathy
    Nawarskas, James J.
    Shephard, Emily A.
    CARDIOLOGY IN REVIEW, 2020, 28 (03) : 156 - 160
  • [27] Tafamidis is entering the clinical arena for the treatment of transthyretin-related cardiomyopathy: certainties and unmet needs
    Rapezzi, Claudio
    Aimo, Alberto
    Emdin, Michele
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (02) : 286 - 289
  • [28] Gender differences in clinical characteristics in wild-type transthyretin amyloidosis cardiomyopathy
    Takashio, S.
    Morioka, M.
    Nishi, M.
    Nakashima, N.
    Yamada, T.
    Hirakawa, K.
    Hanatani, S.
    Usuku, H.
    Yamamoto, E.
    Matsushita, K.
    Kaikita, K.
    Tsujita, K.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1812 - 1812
  • [29] Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
    Maurer, Mathew S.
    Schwartz, Jeffrey H.
    Gundapaneni, Balarama
    Elliott, Perry M.
    Merlini, Giampaolo
    Waddington-Cruz, Marcia
    Kristen, Arnt V.
    Grogan, Martha
    Witteles, Ronald
    Damy, Thibaud
    Drachman, Brian M.
    Shah, Sanjiv J.
    Hanna, Mazen
    Judge, Daniel P.
    Barsdorf, Alexandra I.
    Huber, Peter
    Patterson, Terrell A.
    Riley, Steven
    Schumacher, Jennifer
    Stewart, Michelle
    Sultan, Marla B.
    Rapezzi, Claudio
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11): : 1007 - 1016
  • [30] Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
    Rettl, R. Rene
    Mann, C.
    Duca, F.
    Dachs, T-M
    Binder, C.
    Kronberger, C.
    Dusik, F.
    Ligios, L. Camuz
    Schrutka, L.
    Dalos, D.
    Charwat-Resl, S.
    Kastner, J.
    Eslam, R. Badr
    Bonderman, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 252 - 253
12345